Literature DB >> 16694849

THE LIVER LIPIDS AND THEIR DISTRIBUTION IN DISEASE. AN ANALYSIS OF 60 HUMAN LIVERS.

E P Ralli1, K Paley, S H Rubin.   

Abstract

Entities:  

Year:  1941        PMID： 16694849      PMCID： PMC435073          DOI： 10.1172/JCI101236

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  THE LIVER LIPIDS IN NORMAL HUMAN LIVERS AND IN CASES OF CIRRHOSIS AND FATTY INFILTRATION OF THE LIVER.

Authors:  E P Ralli; S H Rubin; S Rinzler
Journal:  J Clin Invest       Date:  1941-01       Impact factor: 14.808
  1 in total
  5 in total

1.  THE LIPIDS OF SERUM AND LIVER IN PATIENTS WITH HEPATIC DISEASES.

Authors:  E B Man; B L Kartin; S H Durlacher; J P Peters
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

2.  METABOLIC STUDIES IN PATIENTS WITH GASTRO-INTESTINAL CANCER. IV. FAT METABOLISM, A METHOD OF STUDY.

Authors:  P E Rekers; J C Abels; C P Rhoads
Journal:  J Clin Invest       Date:  1943-03       Impact factor: 14.808

3.  Hepatic Lipid Produced by Polyphagia in Albino Rats: Relationships to Dietary Choline and Casein.

Authors:  J S Meyer; W S Hartroft
Journal:  Am J Pathol       Date:  1960-04       Impact factor: 4.307

4.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

5.  HEPATIC VITAMIN A IN THE RAT AS AFFECTED BY THE ADMINISTRATION OF DIBENZANTHRACENE.

Authors:  J C Abels; A T Gorham; S L Eberlin; R Halter; C P Rhoads
Journal:  J Exp Med       Date:  1942-08-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.